Managing clinically significant findings in research: the UK10K example.
about
Feedback of Individual Genetic Results to Research Participants: Is It Feasible in Europe?Evaluating the consent preferences of UK research volunteers for genetic and clinical studiesGenomics of platelet disorders.Returning findings within longitudinal cohort studies: the 1958 birth cohort as an exemplar.The UK10K project identifies rare variants in health and diseaseAnalysis of archived residual newborn screening blood spots after whole genome amplification.ClinLabGeneticist: a tool for clinical management of genetic variants from whole exome sequencing in clinical genetic laboratories.Integrating 400 million variants from 80,000 human samples with extensive annotations: towards a knowledge base to analyze disease cohorts.Canadian Research Ethics Board Leadership Attitudes to the Return of Genetic Research Results to Individuals and Their FamiliesEthical Considerations for the Return of Incidental Findings in Ophthalmic Genomic Research.Human genomics projects and precision medicine.A method for the allocation of sequencing resources in genotyped livestock populations.Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases.Benchmarking distributed data warehouse solutions for storing genomic variant information.Formalising recall by genotype as an efficient approach to detailed phenotyping and causal inference.The ethics conundrum in Recall by Genotype (RbG) research: Perspectives from birth cohort participantsMeeting Patients' Right to the Correct Diagnosis: Ongoing International Initiatives on Undiagnosed Rare Diseases and Ethical and Social Issues
P2860
Q28601041-423A4C38-EC15-4938-A64D-98EDEB0B660BQ28652534-BF365787-9CE7-432C-86B8-570D3D580983Q33433823-7E6808E5-DCCF-4CBF-AF47-942A13EF34E9Q34040535-98F6FF03-9410-4E70-8605-9B17578C906FQ34494047-15F32874-9CD8-42E0-B024-43AA36C9617CQ35744499-82D3AA8B-B596-44B5-B207-6E4FE653B69FQ35764300-E3B5583D-0334-46B6-A8F1-8ECF05C89B94Q35889147-DBE81903-1FE3-496B-994E-5FE36674979DQ36197067-2922EA73-5A5C-44CB-B496-72E14C8040A3Q36590467-0E798F50-D07D-40D4-9DD8-B06CE8E0CB4DQ38626087-56FC1A6A-1E74-42DE-9741-0C8DAE53C8A0Q38776510-E78A9D2F-3C3F-44DD-AA7D-562E2DABF519Q44523764-D9D67CE6-EC79-48BE-A6AA-22B7130653D9Q47113794-C9F46E9F-38BE-41F2-BCA8-933C3E923554Q49830020-71AA29F1-D68D-4B95-A0BD-39A054541DADQ57278039-6B08D933-1A07-4898-8BEF-6A7F081FB965Q58657004-80B83932-3675-4D84-8DA1-20CFBD4E8DD3
P2860
Managing clinically significant findings in research: the UK10K example.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Managing clinically significant findings in research: the UK10K example.
@ast
Managing clinically significant findings in research: the UK10K example.
@en
Managing clinically significant findings in research: the UK10K example.
@nl
type
label
Managing clinically significant findings in research: the UK10K example.
@ast
Managing clinically significant findings in research: the UK10K example.
@en
Managing clinically significant findings in research: the UK10K example.
@nl
prefLabel
Managing clinically significant findings in research: the UK10K example.
@ast
Managing clinically significant findings in research: the UK10K example.
@en
Managing clinically significant findings in research: the UK10K example.
@nl
P2093
P2860
P50
P356
P1476
Managing clinically significant findings in research: the UK10K example.
@en
P2093
Alastair Kent
Carol Smee
David Fitzpatrick
Dawn Muddyman
Francesco Muntoni
Heather Griffin
Jasote Grewal
Karen Kennedy
Lucy F Raymond
Martin Bobrow
P2860
P2888
P304
P356
10.1038/EJHG.2013.290
P577
2014-01-15T00:00:00Z